Dark

PACB
Pacific Biosciences of California, Inc.
stock NASDAQ

At Close

Feb 20, 2026 3:59:58 PM EST

1.62USD-3.571%(-0.06)4,342,005

0.00Bid 0.00Ask 0.00Spread

Pre-market

Feb 20, 2026 9:27:30 AM EST

1.66USD-1.190%(-0.02)6,087

After-hours

Feb 20, 2026 4:34:30 PM EST

1.61USD-0.611%(-0.01)8,296

OverviewOptionsHistoricalExchangesShortsNews

Jan 14, 2022

04:05PM EST PacBio Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Jan 13, 2022

07:00AM EST PacBio Names Lara Toerien as Vice President and General Manager GlobeNewswire Inc

Jan 11, 2022

02:51PM EST Mid-Afternoon Market Update: Dow Rises 150 Points; Accolade Shares Spike Higher Benzinga

12:14PM EST Mid-Day Market Update: Crude Oil Rises 3.5%; Pacific Biosciences of California Shares Fall Benzinga

10:38AM EST 52 Weeks High And Low Article Benzinga

10:07AM EST Mid-Morning Market Update: Markets Down; Albertsons Posts Upbeat Earnings Benzinga

08:36AM EST The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In Benzinga

07:26AM EST PacBio And Berry Genomics Announce Collaboration; PacBio to Develop Long Read Desktop Sequencing Platform With Funding And Guidance Provided By Berry Genomics Benzinga

07:22AM EST PacBio Sees Q4 Sales ~$36M Vs. $36.58M Est., Sees FY21 Sales $130.5M Vs. $131.27M Est. Benzinga

07:20AM EST PacBio (PACB) reported preliminary revenue of approximately $36.0 million for its fourth quarter ended December 31, 2021, an increase of approximately 33% compared with $27.1 million, last year. Preliminary 2021 revenue is expected to be $130.5 million, a growth of approximately 65% from 2020. RTTNews

07:15AM EST New collaboration builds on existing relationship between the two companies to develop desktop systems for the clinical market in China GlobeNewswire Inc

07:12AM EST PacBio Announces Collaboration With Genomics England To Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology Benzinga

07:10AM EST PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics England to study PacBios technology for identifying genetic variants in unexplained rare disease cases. GlobeNewswire Inc

07:08AM EST PacBio Sees Preliminary Fourth Quarter Revenue Of About $36.0 Mln RTTNews

07:05AM EST PacBio and Google Collaborate to Use Machine Learning to Optimize GlobeNewswire Inc

07:00AM EST PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue of approximately $36.0 million for its fourth quarter ended December 31, 2021. The Companys full financial results for the fourth quarter and the fiscal year ended December 31, 2021, are not yet available. GlobeNewswire Inc

Jan 7, 2022

01:04PM EST PacBio Reports Radboud University Medical Center In Nijmegen, Netherlands To Increase Sequencing Capacity With Addition Of 2 New PacBio Sequel IIe Systems, No Terms Disclosed Benzinga

09:00AM EST PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their SMRT sequencing capacity with the addition of two new PacBio Sequel IIe Systems. GlobeNewswire Inc

Jan 6, 2022

09:00AM EST PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will increase PacBios HiFi sequencing platforms across Azentas newly combined company and support Azentas mission to enable life science companies to deliver impactful breakthroughs and therapies to market faster. GlobeNewswire Inc

Jan 5, 2022

09:00AM EST PacBio, a leading provider of high-quality, long-read sequencing platforms, and theCare4Rare Canada Consortium (Care4Rare) announce today they are collaborating to study some of the most complex unexplained rare disease cases within Canada. GlobeNewswire Inc

Jan 4, 2022

04:05PM EST PacBio announced today that its executives will be speaking virtually at the following investor conference: GlobeNewswire Inc

Dec 28, 2021

09:10AM EST PacBio's New HiFiViral Surveillance Kit Performance Is Not Impacted By Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes For All Circulating Variants Benzinga

09:00AM EST PacBios New HiFiViral Surveillance Kit GlobeNewswire Inc

Dec 7, 2021

09:09AM EST PacBio And UCLA Health Announce Research Collaboration For Whole Genome Sequencing In Rare Diseases Benzinga

09:00AM EST PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. GlobeNewswire Inc

Dec 3, 2021

05:00PM EST PacBio Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Nov 30, 2021

09:00AM EST PacBio Names Jason Kang as Vice President and General Manager for GlobeNewswire Inc

Nov 22, 2021

07:00AM EST Organogenesis Appoints Prathyusha Duraibabu to Board of Directors GlobeNewswire Inc

Nov 19, 2021

05:00PM EST PacBio Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Nov 18, 2021

09:05AM EST Pacific Biosciences Reports Collab With ARUP In A Study To Improve Rare Disease Diagnosis Benzinga

09:00AM EST PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and ARUP Laboratories announced today they are collaborating on a study intended to evaluate whether the solve rate for rare disease cases can be increased. GlobeNewswire Inc

Nov 16, 2021

09:12AM EST PacBio Launches HiFiViral SARS-CoV-2 Kit And Microbial Whole Genome Sequencing Enhancements To Combat Infectious Disease And Strengthen Public Health Response To Pathogen Threats Benzinga

09:00AM EST PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the launch of the HiFiViral SARS-CoV-2 Kit a fully kitted end-to-end solution for COVID-19 surveillance, which public health laboratories can use to identify new SARS-CoV-2 variants and detect all variants circulating within a population. GlobeNewswire Inc

Nov 11, 2021

04:05PM EST PacBio announced today that its executives will be speaking at the following investor conferences: GlobeNewswire Inc

Nov 3, 2021

09:14AM EDT Pacific Biosciences Q3 Revenues Jump 83%, Says Sequel II/IIe Installations At All-Time High Benzinga

Nov 2, 2021

06:22PM EDT Pacific Biosciences Q4 Adj. EPS $(0.23) Benzinga

06:04PM EDT Pacific Biosciences Q3 EPS $0.08 Up From $(0.14) YoY, Sales $34.90M Beat $33.23M Estimate Benzinga

05:17PM EDT PacBio Q3 EPS $0.08 Vs. Loss $0.14 Year Ago RTTNews

04:03PM EDT PacBio will be providing its high-quality, highly accurate sequencing platforms to Prenetics Group Limited, a leading global genomics and diagnostic testing company, as the firm adds more comprehensive genetic screening services including carrier screening and cancer-risk screening in Hong Kong, Southeast Asia and in the United Kingdom. GlobeNewswire Inc

10:54AM EDT The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US Benzinga

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

Nov 1, 2021

09:04AM EDT Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Oct. 29, 2021: NTLA, PACB, ACHR, MKFG, BLDE, FB, CDNA, DOC, EXAS, VERV, BEAM Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 19, 2021

04:05PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time. GlobeNewswire Inc

Sep 27, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 Benzinga

09:08AM EDT Pacific Biosciences Of California Reports Partnership With European Reference Genome Atlas Initiative Benzinga

09:00AM EDT PacBio Partners with The European Reference Genome Atlas Initiative GlobeNewswire Inc

08:16AM EDT Canaccord Genuity Initiates Coverage On Pacific Biosciences with Buy Rating, Announces Price Target of $45 Benzinga

Sep 24, 2021

04:05PM EDT Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Sep 20, 2021

04:50PM EDT Pacific Biosciences Of California Filing Shows Registration for ~13.4M Share Common Stock Offering Via Selling Shareholders Benzinga

04:05PM EDT Omniomes high accuracy short-read sequencing platformexpected to significantly expand PacBios market opportunity GlobeNewswire Inc

Sep 3, 2021

09:00AM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: GlobeNewswire Inc

Aug 25, 2021

01:09PM EDT Pacific Biosciences Wins $664K Contract Titled 'Delivery Order issued under USDA Indefinite Delivery Indefinite Quantity (IDIQ) Contract # 12405B21D0002 with Pacific Biosciences of California' Benzinga

Aug 9, 2021

08:00AM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference: GlobeNewswire Inc

Aug 4, 2021

09:26AM EDT Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Lowers Price Target to $41 Benzinga

06:52AM EDT Pacific Biosciences Q2 Earnings Beat Expectations, Higher Operating Costs Widens Quarterly Loss Benzinga

Aug 3, 2021

05:15PM EDT Pacific Biosciences Of California Q2 Loss/share $0.21 Vs. Loss $0.15 Year Ago RTTNews

04:53PM EDT Pacific Biosciences Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $30.60M Beat $29.89M Estimate Benzinga

08:07AM EDT Pacific Biosciences Acquires Circulomics; No Terms Disclosed Benzinga

08:00AM EDT Pacific Biosciences Acquires Circulomics A GlobeNewswire Inc

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Jul 28, 2021

04:05PM EDT Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Jul 20, 2021

10:14AM EDT Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding Benzinga

07:52AM EDT Pacific Biosciences of California, Inc. (PACB), a provider of high-quality, long-read sequencing platforms, Tuesday reported preliminary second-quarter revenue of around $30.5 million, a growth of around 78 percent from last year. RTTNews

07:20AM EDT Pacific Biosciences Agrees To Buy Omniome For Upfront Consideration Of About $600 Mln RTTNews

07:05AM EDT Pacific Biosciences Of California Reports Expansion Of Collaboration With Invitae Benzinga

07:04AM EDT Pacific Biosciences Of California Sees Q2 Sales ~$30.5M vs $29.9M Estimate Benzinga

07:04AM EDT Pacific Biosciences Of California Reports Purchase Of Omniome For $300M In Cash Plus Added $200M In Cash, Stock Payable Related To Certain Milestones Benzinga

07:02AM EDT Collaboration to develop production-scale HiFi Sequencing platformexpected to Include technology from Omniome, Inc. GlobeNewswire Inc

07:00AM EDT -- Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets -- Brings together Omniomes high accuracy short-read sequencing platform, with PacBios market leading, high accuracy long-read solutions -- Transaction supported by concurrent $300 million PIPE financing from premier life science investors GlobeNewswire Inc

Jul 19, 2021

04:05PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time. GlobeNewswire Inc

Jun 23, 2021

04:05PM EDT Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole Genome Sequencing Benzinga

04:05PM EDT Pacific Biosciences and Rady Childrens Institute GlobeNewswire Inc

Jun 11, 2021

04:05PM EDT Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Jun 8, 2021

02:09AM EDT Pacific Biosciences Of California Names Neil Ward To New Role Of VP And General Manager For EMEA Region RTTNews

02:00AM EDT Pacific Biosciences Welcomes Neil Ward to Its Leadership GlobeNewswire Inc

May 21, 2021

04:05PM EDT Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

May 18, 2021

07:44AM EDT The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO Benzinga

May 17, 2021

04:05PM EDT Pacific Biosciences Further Expands Leadership Team with GlobeNewswire Inc

May 16, 2021

05:36PM EDT 'SPACs Attack' Recap: Looking Back At 8 SPAC Deals Plus Latest SPAC Headlines And Earnings Benzinga

May 11, 2021

03:30PM EDT What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry' Benzinga

May 4, 2021

09:00AM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: GlobeNewswire Inc

Apr 29, 2021

05:28PM EDT Pacific Biosciences Of California Q1 Loss/Shr $0.45 Vs EPS $0.01 Last Year RTTNews

05:25PM EDT Pacific Biosciences: Q1 Earnings Insights Benzinga

04:25PM EDT Pacific Biosciences Q1 EPS $(0.45), Inline, Sales $29.00M Beat $25.67M Estimate Benzinga

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

04:10AM EDT Earnings Scheduled For April 29, 2021 Benzinga

Apr 26, 2021

08:00AM EDT -- HiFi Sequencing and Software v10.1 Release on the Sequel II andIIeSystems -- Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads GlobeNewswire Inc

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 22, 2021

04:05PM EDT Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Apr 19, 2021

06:11AM EDT Pacific Biosciences Of California Inc Files For Sale Of 20.7M Shares Of Common Stock By Sb Northstar Lp Benzinga

Apr 15, 2021

04:05PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its first quarter 2021 financial results on Thursday, April 29, 2021, at 4:30pm Eastern Time. GlobeNewswire Inc

Apr 5, 2021

06:59AM EDT Invitae Shares Are Trading Higher On SoftBank's Potential $1.2B Debt Investment: WSJ Benzinga

Mar 2, 2021

04:30PM EST Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Feb 26, 2021

04:04PM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences: GlobeNewswire Inc

Feb 24, 2021

08:00AM EST Childrens Mercy Kansas City Expands Investment GlobeNewswire Inc

Feb 18, 2021

08:03AM EST Pacific Biosciences Announces LabCorp Will Use PacBio's HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S. Benzinga

08:01AM EST Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global GlobeNewswire Inc

Feb 12, 2021

08:39AM EST Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Raises Price Target to $45 Benzinga

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Feb 10, 2021

04:24PM EST Pacific Biosciences: Q4 Earnings Insights Benzinga

04:07PM EST Pacific Biosciences Q4 EPS $0.37 Beats $0.32 Estimate, Sales $27.14M Beat $25.41M Estimate Benzinga

04:02PM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December31, 2020. Reported revenue is consistent with the Companys press release issued on January 11, 2021. GlobeNewswire Inc

03:57PM EST Notable After-Hours Earnings For Wednesday, Feb. 10, 2021 And Expected Report Times: CERN, RDFN, IRBT, PACB, KERN, TRUP, ATUS, SONO, ZG, ZNGA, PAYC, QUOT, UBER, SAVE, SSNC, MOH, CXW, MGM, ORLY, EFX, KGC, EXEL, PPC Benzinga

08:22AM EST Pacific Biosciences of California, Inc. (PACB), a provider of long-read sequencing platforms, said Wednesday that SB Management will make an investment of $900 million in convertible senior notes to support the company's future growth initiatives. SB Management is a subsidiary of Japanese conglomerate Softbank Group Corp. (SFTBY.PK, SFTBF.PK). RTTNews

08:12AM EST Pacific Biosciences Announces $900M Investment From Softbank To Support Growth Initiatives; Softbank Unit SB Management Will Make Investment Of $900M In Convertible Senior Notes With Initial Conversion Price Of $43.50/Share Benzinga

08:09AM EST Pacific Biosciences Secures $900 Mln Investment From SoftBank RTTNews

08:00AM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the Company), a leading provider of high-quality, long-read sequencing platforms, today announced that SB Management, a subsidiary of Softbank Group Corp., will make an investment of $900 million in convertible senior notes to support the Companys future growth initiatives. GlobeNewswire Inc

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

05:20AM EST SoftBank To Invest $900M In Pacific Biosciences - WSJ Benzinga

03:43AM EST Earnings Scheduled For February 10, 2021 Benzinga

Feb 9, 2021

10:23AM EST Pacific Biosciences Earnings Preview Benzinga

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Feb 5, 2021

05:00PM EST Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Jan 28, 2021

07:24PM EST CORRECTION: Cathie Wood's ARK Invests Posts Stock Sales For Thursday, Jan. 28, 2021: GOOGL, PACB, ROKU, MTLS Benzinga

Jan 27, 2021

02:30PM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. GlobeNewswire Inc

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 13, 2021

08:10AM EST Pacific Biosciences And Invitae To Develop 'Ultra-High-Throughput Clinical Whole Genome Sequencing Platform' Benzinga

08:02AM EST Pacific Biosciences and Invitae to Develop Ultra-High-Throughput GlobeNewswire Inc

Jan 12, 2021

06:27PM EST Pacific Biosciences Grants Equity Incentive Awards to New Employees GlobeNewswire Inc

Jan 11, 2021

10:03AM EST Pacific Biosciences shares were trading higher after SoftBank acquired a 6% stake in the company. Benzinga

07:49AM EST Pacific Biosciences of California Sees Q4 Sales ~$27M Vs. $23.69M Est. Benzinga

07:49AM EST Pacific Biosciences Of California Expects Preliminary Q4 Revenue To Be $27 Mln RTTNews

07:45AM EST Pacific Biosciences of California, Inc. (the Company) (NASDAQ: PACB), a leading provider of high-quality sequencing platforms, today announced unaudited preliminary revenue of approximately $27 million for its fourth quarter ended December 31, 2020. The Companys full financial results for the fourth quarter and the fiscal year ended December 31, 2020 are not yet available. GlobeNewswire Inc

Jan 8, 2021

03:16PM EST SoftBank Is Said To Take ~6% Stake In Pacific Biosciences Benzinga

08:45AM EST Pacific Biosciences Announces Appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer Benzinga

08:45AM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. GlobeNewswire Inc

08:07AM EST Pacific Biosciences Of California: Wellcome Sanger Institute Commits To Buy 7 New Sequel IIe Systems RTTNews

08:00AM EST Wellcome Sanger Institute Increases Investment in PacBio Long-Read GlobeNewswire Inc

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Dec 29, 2020

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

Dec 23, 2020

08:31AM EST The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut Benzinga

Dec 22, 2020

07:45AM EST The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga

Dec 18, 2020

04:05PM EST Pacific Biosciences Grants Equity Incentive Award to New Employee GlobeNewswire Inc

Dec 16, 2020

08:13AM EST Pacific Biosciences Of California Reports Initial Findings From Co.'s Research Collaboration With Labcorp Focused On SARS-CoV-2, Related Immune Response To COVID-19 Benzinga

08:00AM EST Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced initial findings from the companys research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19. GlobeNewswire Inc

Dec 15, 2020

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

Dec 14, 2020

05:40PM EST Watching Pacific Biosciences Shares Following Beta.Sam.gov Contract Listing For Lab Equipment, Supplies Via Dept. Of Agriculture, No Terms Disclosed Benzinga

08:11AM EST Pacific Biosciences Reports UK Core Labs Expands Investment In Co's Sequencing Systems To Power Life Science Research With HiFi Reads Benzinga

08:00AM EST Leading UK Core Labs Expand Investment in PacBio Sequencing GlobeNewswire Inc

Dec 10, 2020

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

Dec 9, 2020

11:08AM EST Cramer Gives His Opinion On Quest Diagnostics, HanesBrands And More Benzinga

Dec 8, 2020

08:04AM EST The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings Benzinga

Dec 7, 2020

11:56AM EST Pacific Biosciences Option Alert: Jan 15 $23 Calls Sweep (32) above Ask!: 312 @ $2.252 vs 21 OI; Earnings 2/4 After Close [est] Ref=$22.27 Benzinga

Dec 4, 2020

08:04AM EST The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs Benzinga

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Nov 13, 2020

07:40AM EST The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations Benzinga

Nov 12, 2020

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

Nov 11, 2020

01:28PM EST Yahoo Finance Trending Stocks For Wednesday, Nov. 11, 2020: FPRX, DDOG, FTEK, VXRT, RKT, PLUG, SRNE, REV, GNUS, SPCE, MYO, FUBO, MRNA, PSHG, IMRN, MAPT, LYFT, BRKS, PACB, APD, NKLA, QCOM, MOMO, OASPQ, LMND, COHR, PDD, EQ, MDGS Benzinga

07:38AM EST The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap Benzinga

06:53AM EST Pacific Biosciences Of California shares were trading lower after the company announced a common stock offering of 7.4 million shares at $14.25 per share. Benzinga

05:45AM EST Pacific Biosciences of California Priced 7.4M Share Offering @ $14.25/Share Benzinga

Nov 10, 2020

04:15PM EST Pacific Biosciences Of California Announces A $85M Share Common Stock Offering Benzinga

04:05PM EST Pacific Biosciences of California, Inc. Announces Proposed Public GlobeNewswire Inc

08:40AM EST The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies Benzinga

Nov 4, 2020

08:32AM EST Morgan Stanley Maintains Equal-Weight on Pacific Biosciences, Raises Price Target to $12 Benzinga

Nov 3, 2020

09:33AM EST Benzinga's Top Upgrades, Downgrades For November 3, 2020 Benzinga

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

05:03AM EST Piper Sandler Downgrades Pacific Biosciences to Neutral Benzinga

Nov 2, 2020

04:46PM EST Pacific Biosciences: Q3 Earnings Insights Benzinga

04:04PM EST Pacific Biosciences Q3 EPS $(0.14) Misses $(0.13) Estimate Benzinga

04:02PM EST Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. GlobeNewswire Inc

07:55AM EST Earnings Scheduled For November 2, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 22, 2020

08:11AM EDT Invitae And Pacific Biosciences Announced That The Company's Will Collaborate To Develop Whole Genome Sequengc-Based Assays For Peduatri Epilepsy Diagnostics Benzinga

08:00AM EDT Invitae and Pacific Biosciences Collaborate to Develop Whole GlobeNewswire Inc

Oct 21, 2020

08:04AM EDT The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings Benzinga

Oct 20, 2020

08:17AM EDT The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger Benzinga

06:10AM EDT Pacific Biosciences Of California On Oct. 14 Appointed Christian Henry As President Of In Addition To His Title As CEO Benzinga

Oct 19, 2020

12:30PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial Results on Monday, November 2, 2020, at 4:30pm Eastern Time. GlobeNewswire Inc

Oct 15, 2020

08:01AM EDT Childrens Mercy Kansas City Teams Up with GlobeNewswire Inc

Oct 6, 2020

10:35AM EDT Shares of Pacific Biosciences of California, Inc. (PACB) are losing more than 5 percent or $0.67 in Tuesday's morning trade at $12.07, after touching a new 52-week high of $12.90. RTTNews

Oct 5, 2020

08:10AM EDT Pacific Biosciences Of California Announces Launch Of The Sequel IIe System RTTNews

08:00AM EDT Pacific Biosciences Launches the Sequel IIe Systemto GlobeNewswire Inc

Oct 2, 2020

10:21AM EDT Shares of Pacific Biosciences of California, Inc. (PACB) are gaining more than 8 percent or $0.90 in Friday's morning trade at $11.40, after touching a new 52-week high of $11.72 despite no specific news that could influence the stock. RTTNews

04:56AM EDT JP Morgan Upgrades Pacific Biosciences to Overweight, Announces $15 Price Target Benzinga

Oct 1, 2020

10:06AM EDT Piper Sandler Maintains Overweight on Pacific Biosciences, Raises Price Target to $12 Benzinga

Sep 14, 2020

10:36AM EDT Pacific Biosciences Of California Appoints Susan Kim As CFO September 28 RTTNews

09:15AM EDT Pacific Biosciences Of California Appoints Susan Kim As CFO RTTNews

09:02AM EDT Pacific Biosciences Appoints Susan G. Kim As Chief Financial Officer Benzinga

09:00AM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, 2020. GlobeNewswire Inc

Sep 9, 2020

09:45AM EDT Benzinga's Top Upgrades, Downgrades For September 9, 2020 Benzinga

08:16AM EDT Morgan Stanley Initiates Coverage On Pacific Biosciences with Equal-Weight Rating, Announces Price Target of $7 Benzinga

Aug 12, 2020

04:45PM EDT 04:45 Wednesday, August 12, 2020 RTTNews

10:13AM EDT Shares of Pacific Biosciences of California, Inc. (PACB) are climbing almost 22 percent or $0.97 in Wednesday's morning trade at $5.44. RTTNews

09:53AM EDT Morning Market Stats in 5 Minutes Benzinga

05:41AM EDT Pacific Biosciences Prices 19M Share Public Offering of Common Stock @$4.47/Share Benzinga

Aug 11, 2020

11:21PM EDT Pacific Biosciences of California, Inc. Announces Pricing of GlobeNewswire Inc

04:44PM EDT Pacific Biosciences Of California, Inc. Announces Proposed $75M Public Offering Of Common Stock Benzinga

04:32PM EDT Pacific Biosciences of California, Inc. Announces Proposed Public GlobeNewswire Inc

Aug 7, 2020

08:35AM EDT Pacific Biosciences Appoints Christian O. Henry New Chief Executive Officer Benzinga

08:30AM EDT Christian O. Henry Named Chief Executive OfficerJohn F. Milligan, Ph.D. Named Chairman of the BoardBen Gong Named Interim CFO GlobeNewswire Inc

Aug 3, 2020

04:05PM EDT Pacific Biosciences Q2 EPS $(0.15) Beats $(0.18) Estimate, Sales $17.10M Beat $13.72M Estimate Benzinga

04:02PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2020. GlobeNewswire Inc

08:11AM EDT Pacific Biosciences And Asuragen Collaborate To Develop Assays For Carrier Screening And Other Applications Based On SMRT Sequencing Technology And AmplideX PCR Chemistry Benzinga

08:00AM EDT Pacific Biosciences and Asuragen Collaborate to Develop Assays for GlobeNewswire Inc

04:13AM EDT Earnings Scheduled For August 3, 2020 Benzinga

Jul 24, 2020

12:07PM EDT Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Second Quarter 2020 Financial Results on Monday, August 3, 2020, at 4:30pm Eastern Time. GlobeNewswire Inc